COVID-19 Antibody IgG w/reflex to ACE2 Blocking Antibody

ORDER CODE: COV2IGGPLEX

ORDERING

SPECIMEN

PROCESSING

Positive serology results will to reflex to an ACE2 blocking assay

Test Code

SHC TEST CODE LPCH TEST CODE
LABCOV2IGGPLEX LABCOV2IGGPLEX

Specialty

Infectious Disease

Synonyms

COVID, SARS, COV2TAB, NOVEL, CORONA, SARS, COV2IGG, COV2IGM, COV2IGA, COVID, SARSCOV2, SARS-COV-2, CORONAVIRUS, NCOV, 2019

Clinical Utility

Provides quantitative assessment of patient's humoral response to COVID-19 vaccination or infection. Quantitative results against various COVID-19 antigens will help trend antibody response over time and can be compared to results of SARS-CoV-2 vaccine efficacy data and alongitudinal studies of patient antibody responses following infection.

CPT Code

86769
Collection Instructions

Collect blood following standard venipuncture collection procedures.

Preferred Specimen(s)
Plasma
Container Type
Mint-top (Lithium Heparin) preferred or Lavender-top (EDTA) acceptable
Container Image 1 Container Image 2

Specimen Quantity and Stability

Special Handling

Specimens should be delivered to the laboratory as soon as possible. If transport is delayed, specimens (whether separation of plasma has occurred or not) should be refrigerated 2-8C.

Causes for Rejection

The following specimens are not appropriate for testing: grossly hemolyzed, lipemic, icteric, heat inactivated plasma, or specimens with obvious microbial contamination. Plasma samples must not contain particulate matter. Consult the Supervisor/ Reference CLS/Superuser for resolution of any abnormal samples if needed.

Department

Virology

Methodology

Electrochemiluminescent Immunoassay (ECL)

Standard Run Time(s)

Once every 2 weeks

Turnaround Time

ROUTINE STAT
14 days n/a

Positive serology results will to reflex to an ACE2 blocking assay

Test Code

SHC TEST CODE LPCH TEST CODE
LABCOV2IGGPLEX LABCOV2IGGPLEX

Specialty

Infectious Disease

Synonyms

COVID, SARS, COV2TAB, NOVEL, CORONA, SARS, COV2IGG, COV2IGM, COV2IGA, COVID, SARSCOV2, SARS-COV-2, CORONAVIRUS, NCOV, 2019

Clinical Utility

Provides quantitative assessment of patient's humoral response to COVID-19 vaccination or infection. Quantitative results against various COVID-19 antigens will help trend antibody response over time and can be compared to results of SARS-CoV-2 vaccine efficacy data and alongitudinal studies of patient antibody responses following infection.

CPT Code

86769

close ORDERING
Collection Instructions

Collect blood following standard venipuncture collection procedures.

Preferred Specimen(s)
Plasma
Container Type
Mint-top (Lithium Heparin) preferred or Lavender-top (EDTA) acceptable
Container Image 1 Container Image 2

Specimen Quantity and Stability

Special Handling

Specimens should be delivered to the laboratory as soon as possible. If transport is delayed, specimens (whether separation of plasma has occurred or not) should be refrigerated 2-8C.

Causes for Rejection

The following specimens are not appropriate for testing: grossly hemolyzed, lipemic, icteric, heat inactivated plasma, or specimens with obvious microbial contamination. Plasma samples must not contain particulate matter. Consult the Supervisor/ Reference CLS/Superuser for resolution of any abnormal samples if needed.


close SPECIMEN

Department

Virology

Methodology

Electrochemiluminescent Immunoassay (ECL)

Standard Run Time(s)

Once every 2 weeks

Turnaround Time

ROUTINE STAT
14 days n/a

close PROCESSING

close RESULTS